Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05742061
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-02-23
First Post:
2023-02-01
Brief Title:
Intra-articular Platelet Rich Plasma vs Corticosteroid in Treatment of Knee Osteoarthritis Patients
Sponsor:
Benha University
Organization:
Benha University
Study Overview
Official Title:
Intra-articular Platelet Rich Plasma vs Corticosteroid in Treatment of Knee Osteoarthritis
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Knee osteoarthritis is the most common type of osteoarthritis in the lower extremity and constitutes 23 of all arthritis cases about 13 of females and 10 of males aged above 60 years have symptomatic knee OA Intra-articular corticosteroids IACs are a frequently-used treatment regimen for pain relief from symptomatic knee OA as it inhibits inflammation and reduces prostaglandin synthesis Platelet-rich plasma PRP is an autologous blood product containing a high percentage of various growth factors GFs such as fibroblast growth factor epidermal growth factor vascular endothelial growth factor transforming growth factor-β and platelet-derived growth factor The aim of this study is to compare effect of intra-articular injection of platelet rich plasma versus corticosteroid in treatment of primary knee osteoarthritis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None